The effect of HDAC9 on cell proliferation is coupled to a reduced sensitivity of breast cancer cells to the antiproliferative and apoptotic activity of HDIs, similar to that observed in cells of basal type as compared to luminal ones. This evidence concerns the gene HDAC9 and breast cancer.